MAIL

Translational disconnect I enjoyed the article by Alan Walton and Frederick Frank entitled "Translational disconnect," in which they discuss ways to approach the crisis in bioscience innovation. 1 I applaud the establishment of the Committee on Bioscience Innovations, of which I knew nothing until reading this article. I

Written byThe Scientist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

I enjoyed the article by Alan Walton and Frederick Frank entitled "Translational disconnect," in which they discuss ways to approach the crisis in bioscience innovation. 1 I applaud the establishment of the Committee on Bioscience Innovations, of which I knew nothing until reading this article.

I have two suggestions for improving the performance of pharmaceutical companies in the discovery of novel pharmaceuticals for diseases, old and new. The first is to increase patent protection from 17 to 25 years. The second is to ban advertising of medical products, especially on TV, a suggestion that would eliminate the huge advertising budgets of the pharmaceutical companies, which exceeds the amount spent on research in much of Big Pharma, and would liberate the funds for needed research.

Arnold Demain
Research Institute for Scientists Emeriti
Drew University
Madison, NJ
ademain@drew.edu

Walton and Frank point out "that many foreign students return to their own countries ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies